查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1831955

2025 年至 2033 年组织库市场报告（按产品、应用、组织类型和地区）

Tissue Banking Market Report by Product, Application, Tissue Type, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 149 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球组织库市场规模达20亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到46亿美元，2025-2033年期间的复合年增长率（CAGR）为9.6%。蓬勃发展的研发投入、冷冻保存技术的进步、慢性病和遗传性疾病的增加、个人化医疗需求的不断增长、基因组学的进步、监管的进步、战略合作以及研究人员意识的增强，都是推动市场成长的一些因素。

组织库市场趋势：

增加研发投入

全球组织库市场的成长主要得益于研发投入的不断增加，尤其是在再生医学和个人化治疗领域。随着科学界和医学界对疾病理解和治疗的不断进步，组织样本捐赠数量显着增长，这进一步推动了市场的成长。这些样本对于理解疾病的生物机制、测试新药的潜在疗效以及识别可能受益于特定药物的患者群体至关重要。随着干细胞治疗和基因编辑等领域研究的进展，人们对特定组织样本的依赖日益加深，进一步增加了对保存完好、人人可用的组织库的需求。例如，加州大学旧金山分校最近启动了全球首个组织库，其样本来自新冠肺炎患者捐赠。先前有研究表明，新冠病毒可以在人体内持续存活，这可能是了解这种残疾疾病病因并找到有效治疗方法的关键。

低温保存技术的进展

冷冻保存技术的发展是推动全球组织库市场发展的主要因素之一。冷冻保存是一种将活组织和细胞在冰点以下储存并保持其活力的有效方法。快速发展的技术加速了这一进程，大大提高了保存组织的品质和耐久性。此外，新的冷冻保护剂和冷却技术也得到了发展，例如玻璃化冷冻技术可以防止冰晶形成，避免冰晶破坏细胞结构。此外，冷冻保存的自动化进一步提高了操作的自动化程度，有助于最大限度地减少人为错误并提高处理量，从而促进了市场的成长。

慢性病和遗传性疾病的盛行率不断上升

遗传疾病和慢性病发病率的不断上升是加速全球组织库市场发展的主要因素之一。根据沙乌地阿拉伯全国人口调查，成年男性和女性的糖尿病 (DM) 盛行率估计为男性 14.8%，而女性盛行率较低，为 11.7%。癌症、心血管疾病和糖尿病等慢性疾病需要深入研究，以了解其病理生理机制并开发有效的治疗方法。组织库为此类研究提供了至关重要的资源，它提供了种类繁多的生物样本，对于研究疾病机制、开发新药和测试疗效至关重要。

组织库市场区隔：

按产品分类：

  • 装置
    • 低温保存设备
    • 解冻设备
    • 品质管制设备
    • 其他的
  • 介质和耗材

设备占大部分市场份额

设备细分市场的发展动力源自于市场对先进且可靠的组织保存和分析系统日益增长的需求。自动化和改进的冷冻保存技术等技术进步对于提高组织处理和储存的效率和准确性至关重要。研究活动和临床试验的增多需要最先进的设备来确保高品质和可重复的结果。此外，个人化医疗和再生疗法的日益增长的关注也推动了对能够管理多样化和复杂组织样本的专用设备的需求。品质和安全标准的监管要求进一步推动了先进设备的采用。医疗基础设施投资的增加以及全球组织库的扩张也推动了对先进设备的需求。

按应用分类：

  • 疗法
  • 医学研究
  • 其他的

治疗学占行业最大份额

个人化医疗需求的日益增长推动了治疗领域的发展，个人化医疗需要使用特定的高品质组织样本来根据个别基因图谱制定个人化治疗方案。基因组学和生物技术的进步进一步推动了这一增长，因为它们使研究人员和临床医生能够更好地理解复杂的疾病机制并开发标靶疗法。此外，慢性病和遗传性疾病的盛行率不断上升，加速了对创新治疗方案的需求，导致研发活动激增。药物研发领域的技术进步，包括高通量筛选和复杂的生物资讯工具，也至关重要，因为它们依赖多样化且特征明确的生物样本来识别和验证新的治疗标靶。再生医学和细胞疗法（例如干细胞治疗和组织工程）的日益重视，推动了对强大的组织库基础设施的需求，这些基础设施为这些尖端疗法提供了必要的材料。

依组织类型分类：

  • 心血管组织
  • 肺组织
  • 肾臟组织
  • 胰臟组织
  • 肝组织
  • 眼纸
  • 其他的

心血管组织代表着领先的细分市场

心血管疾病 (CVD) 的发生率不断上升，是全球主要死亡原因之一，心血管组织细分市场因此蓬勃发展。 CVD 病例的激增需要大量的研发投入，从而推动了对高品质心血管组织的需求，用于研究疾病机制、开发创新疗法和测试治疗干预措施。组织工程和再生医学的进步也至关重要，因为它们使得创建和使用心血管组织能够开发个人化疗法并改善患者预后。对个人化医疗的日益重视进一步推动了需求，因为临床医生需要寻找与患者个体特征相符的组织样本，以便制定更有效的治疗方案。此外，生物样本库技术的不断进步，包括改进的保存方法和更优的组织表征技术，提高了心血管组织的品质和可用性。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大的组织库市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是组织库最大的区域市场。

北美地区市场受医疗保健研究和生物技术投资不断增长的驱动，这显着增强了对高品质组织样本的需求。该地区拥有先进的研究机构和蓬勃发展的製药业，这加速了对维护良好的组织样本库的需求，以支持再生医学、个人化治疗和药物开发领域的创新研究。此外，北美慢性病和遗传性疾病的发生率不断上升，推动了对多样化组织样本的需求，以了解疾病机制并开发有效的治疗方法。冷冻保存和组织储存技术的进步进一步促进了市场发展，提供了延长保存组织活力并提高整体研究品质的解决方案。北美的监管环境也发挥着至关重要的作用；严格的标准和准则确保了组织样本库实践的品质和安全，从而增强了人们对组织样本库的信任和可靠性。

本报告回答的关键问题

  • 2024 年全球组织库市场规模是多少
  • 2025-2033年全球组织库市场的预期成长率是多少
  • 推动全球组织库市场的关键因素有哪些
  • COVID-19 对全球组织库市场有何影响
  • 根据产品类型，全球组织库市场如何划分？
  • 根据应用情况，全球组织库市场如何划分
  • 根据组织类型，全球组织库市场如何划分
  • 全球组织库市场的主要区域有哪些
  • 全球组织库市场的主要参与者/公司有哪些

本报告回答的关键问题

  • 2024年全球组织库市场规模？ 2025-2033年全球组织库市场的预期成长率是多少？
  • 推动全球组织库市场发展的关键因素有哪些？
  • COVID-19 对全球组织库市场有何影响？
  • 根据产品，全球组织库市场是如何分布的？
  • 根据应用，全球组织库市场是如何分布的？
  • 根据组织类型，全球组织库市场是如何分類的？
  • 全球组织库市场的主要区域有哪些？
  • 全球组织库市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球组织库市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 装置
    • 关键部分
      • 低温保存设备
      • 解冻设备
      • 品质管制设备
      • 其他的
  • 介质和耗材

第七章：市场区隔：依应用

  • 疗法
  • 医学研究
  • 其他的

第八章：市场区隔：依卫生纸类型

  • 心血管组织
  • 肺组织
  • 肾臟组织
  • 胰臟组织
  • 肝组织
  • 眼纸
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • AMS Biotechnology
    • Beckman Coulter Inc. (Danaher Corporation)
    • Bio-Rad Laboratories Inc.
    • Brooks Life Sciences Inc. (Brooks Automation Inc.)
    • Eppendorf AG
    • Merck KGaA
    • PHC Corporation
    • QIAGEN NV
    • Sartorius AG
    • Taylor-Wharton
    • Thermo Fisher Scientific Inc.
    • VWR International LLC (Avantor Inc)
Product Code: SR112025A4764

The global tissue banking market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.6 Billion by 2033, exhibiting a growth rate (CAGR) of 9.6% during 2025-2033. The burgeoning research and development (R&D) investments, advancements in cryopreservation, the rise in chronic diseases and genetic disorders, growing demand for personalized medicine, improvements in genomics, regulatory advancements, strategic collaborations, and enhanced awareness among researchers are some of the factors boosting the market growth.

Tissue Banking Market Trends:

Increasing Investments in Research and Development

The global tissue banking market is predominantly driven in growth by the increasing investment in R&D, especially for regenerative medicine and personalized therapies. With the advancements in disease understanding and treatment by scientific and medical communities, there is a significant growth in tissue sample donations, which is further fueling the market growth. These samples are key to understanding the biology of disease, testing new drugs for potential use in patients, and identifying patient populations that may benefit from a particular drug. As research progresses in fields such as stem cell therapy and gene editing, it thrusts the reliance on specific tissue samples, further increasing the demand for well-preserved banks of tissues accessible by everyone. For instance, recently, UC San Francisco launched the world's first tissue bank with samples donated by patients with long COVID. The move follows research indicating that the virus can continue to linger throughout the body and may hold the key to understanding the cause of the debilitating disorder and lead to effective treatments.

Advances in Cryopreservation Technologies

The development of cryopreservation technologies is one of the major factors which is pushing the global tissue banking market. Cryopreservation is an effective way to store living tissue and cells below freezing temperatures while keeping it viable. Rapidly advancing technologies have accelerated this process, making the quality of preserved tissues and their durability much better. Additionally, new cryoprotectants and cooling techniques are developed, such as vitrification that prevents ice crystal formation, which can otherwise damage cell structures. Moreover, automation in cryopreservation further automates the operations and helps in minimizing human error and increasing throughput, which is bolstering the market growth.

Growing Prevalence of Chronic Diseases and Genetic Disorders

The growing incidence of genetic diseases and chronic conditions is one of the primary factor accelerating the global tissue banking market. As per the national survey carried out in Saudi population, Diabetes Mellitus (DM) among adult males and females were estimated with prevalence rates 14.8% for male, while it was lower for female group where 11.7%. Chronic conditions such as cancer, cardiovascular diseases, and diabetes require extensive research to understand their pathophysiology and develop effective treatments. Tissue banks provide critical resources for this research by offering a diverse array of biological samples, which are essential for studying disease mechanisms, developing new drugs, and testing treatment efficacy.

Tissue Banking Market Segmentation:

Breakup by Product:

  • Equipment
    • Cryopreservation Equipment
    • Thawing Equipment
    • Quality Control Equipment
    • Others
  • Media and Consumables

Equipment accounts for the majority of the market share

The equipment segment is driven by the increasing demand for advanced and reliable systems for tissue preservation and analysis. Technological advancements, such as automation and improved cryopreservation techniques, are crucial in enhancing the efficiency and accuracy of tissue handling and storage. The rise in research activities and clinical trials necessitates state-of-the-art equipment to ensure high-quality and reproducible results. Additionally, the growing focus on personalized medicine and regenerative therapies fuels the need for specialized equipment capable of managing diverse and complex tissue samples. Regulatory requirements for quality and safety standards further drive the adoption of sophisticated equipment. Increased investments in healthcare infrastructure and the expansion of tissue banks globally also contribute to the demand for advanced equipment.

Breakup by Application:

  • Therapeutics
  • Medical Research
  • Others

Therapeutics holds the largest share of the industry

The therapeutics segment is driven by the increasing demand for personalized medicine, which necessitates the use of specific, high-quality tissue samples to tailor treatments to individual genetic profiles. Advances in genomics and biotechnology further fuel this growth, as they enable researchers and clinicians to better understand complex disease mechanisms and develop targeted therapies. Additionally, the rising prevalence of chronic diseases and genetic disorders accelerates the need for innovative therapeutic solutions, leading to a surge in research and development activities. Technological advancements in drug discovery, including high-throughput screening and sophisticated bioinformatics tools, are also pivotal, as they rely on diverse and well-characterized biological samples to identify and validate new therapeutic targets. The growing emphasis on regenerative medicine and cell therapies, such as stem cell treatments and tissue engineering, drives demand for robust tissue banking infrastructure, which provides essential materials for these cutting-edge therapies.

Breakup by Tissue Type:

  • Cardiovascular Tissue
  • Lung Tissue
  • Kidney Tissue
  • Pancreas Tissue
  • Liver Tissue
  • Eye Tissue
  • Others

Cardiovascular Tissue represents the leading market segment

The cardiovascular tissue segment is driven by the increasing prevalence of cardiovascular diseases (CVDs), which are among the leading causes of mortality globally. This surge in CVD cases necessitates extensive research and development efforts, fueling the demand for high-quality cardiovascular tissues for studying disease mechanisms, developing innovative treatments, and testing therapeutic interventions. Advances in tissue engineering and regenerative medicine are also pivotal, as they enable the creation and use of cardiovascular tissues for developing personalized therapies and improving patient outcomes. The growing emphasis on personalized medicine further drives demand, as clinicians seek tissue samples that match individual patient profiles for more effective treatment plans. Additionally, ongoing advancements in biobanking technologies, including improved preservation methods and better tissue characterization techniques, enhance the quality and availability of cardiovascular tissues.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest tissue banking market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for tissue banking.

The North America regional market is driven by the increasing investments in healthcare research and biotechnology, which significantly bolster the demand for high-quality tissue samples. The presence of advanced research institutions and a robust pharmaceutical industry in the region accelerates the need for well-maintained tissue banks to support innovative studies in regenerative medicine, personalized therapies, and drug development. Additionally, the growing prevalence of chronic diseases and genetic disorders in North America drives the need for diverse tissue samples to understand disease mechanisms and develop effective treatments. Technological advancements in cryopreservation and tissue storage further enhance the market, providing solutions that extend the viability of preserved tissues and improve overall research quality. The regulatory landscape in North America also plays a crucial role; stringent standards and guidelines ensure the quality and safety of tissue banking practices, which in turn fosters trust and reliability in tissue banks.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the tissue banking industry include AMS Biotechnology, Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., Brooks Life Sciences Inc. (Brooks Automation Inc.), Eppendorf AG, Merck KGaA, PHC Corporation, QIAGEN N.V., Sartorius AG, Taylor-Wharton, Thermo Fisher Scientific Inc., VWR International LLC (Avantor Inc), etc.
  • Key players in the tissue banking market are actively engaged in a variety of strategic initiatives to enhance their market position and drive innovation. Leading companies are investing heavily in R&D to advance cryopreservation technologies, improve tissue storage methods, and develop new applications for tissue samples. This includes implementing cutting-edge automation and digital solutions to streamline operations, increase efficiency, and ensure high-quality preservation of biological materials. Additionally, these players are expanding their global footprint by establishing new tissue banks and forming strategic partnerships with academic institutions, biopharmaceutical companies, and healthcare organizations. To address the growing demand for specialized and well-characterized tissue specimens, key players are also focusing on diversifying their tissue collections and incorporating advanced genomic and molecular characterization techniques. Moreover, regulatory compliance and the establishment of rigorous quality control standards are priorities, ensuring that their practices meet international guidelines and enhance the reliability of tissue resources.

Key Questions Answered in This Report

  • 1.What was the size of the global tissue banking market in 2024?
  • 2.What is the expected growth rate of the global tissue banking market during 2025-2033?
  • 3.What are the key factors driving the global tissue banking market?
  • 4.What has been the impact of COVID-19 on the global tissue banking market?
  • 5.What is the breakup of the global tissue banking market based on the product?
  • 6.What is the breakup of the global tissue banking market based on the application?
  • 7.What is the breakup of the global tissue banking market based on the tissue type?
  • 8.What are the key regions in the global tissue banking market?
  • 9.Who are the key players/companies in the global tissue banking market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tissue Banking Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Cryopreservation Equipment
      • 6.1.2.2 Thawing Equipment
      • 6.1.2.3 Quality Control Equipment
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Media and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Therapeutics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Medical Research
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Tissue Type

  • 8.1 Cardiovascular Tissue
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Lung Tissue
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Kidney Tissue
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pancreas Tissue
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Liver Tissue
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Eye Tissue
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AMS Biotechnology
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Brooks Life Sciences Inc. (Brooks Automation Inc.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Eppendorf AG
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 PHC Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 QIAGEN N.V.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sartorius AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Taylor-Wharton
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 VWR International LLC (Avantor Inc)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Tissue Banking Market: Major Drivers and Challenges
  • Figure 2: Global: Tissue Banking Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Tissue Banking Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Tissue Banking Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Tissue Banking Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Tissue Banking Market: Breakup by Tissue Type (in %), 2024
  • Figure 7: Global: Tissue Banking Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Tissue Banking (Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Tissue Banking (Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Tissue Banking (Media and Consumables) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Tissue Banking (Media and Consumables) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Tissue Banking (Therapeutics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Tissue Banking (Therapeutics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Tissue Banking (Medical Research) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Tissue Banking (Medical Research) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Tissue Banking (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Tissue Banking (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Tissue Banking (Cardiovascular Tissue) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Tissue Banking (Cardiovascular Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Tissue Banking (Lung Tissue) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Tissue Banking (Lung Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Tissue Banking (Kidney Tissue) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Tissue Banking (Kidney Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Tissue Banking (Pancreas Tissue) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Tissue Banking (Pancreas Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Tissue Banking (Liver Tissue) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Tissue Banking (Liver Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Tissue Banking (Eye Tissue) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Tissue Banking (Eye Tissue) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Tissue Banking (Other Tissue Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Tissue Banking (Other Tissue Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Tissue Banking Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Tissue Banking Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Tissue Banking Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Tissue Banking Industry: SWOT Analysis
  • Figure 82: Global: Tissue Banking Industry: Value Chain Analysis
  • Figure 83: Global: Tissue Banking Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tissue Banking Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Tissue Banking Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Tissue Banking Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Tissue Banking Market Forecast: Breakup by Tissue Type (in Million USD), 2025-2033
  • Table 5: Global: Tissue Banking Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Tissue Banking Market: Competitive Structure
  • Table 7: Global: Tissue Banking Market: Key Players